Cristina Ghirelli

Cristina Ghirelli has extensive work experience in the field of immunology and cancer research. Cristina currently serves as the Research Operations Director at Imcheck Therapeutics since November 2021. Prior to this, they worked as a Scientific Editor at INSERM U976 HIPI from May 2021 to November 2021.

From 2015 to 2020, Cristina worked at Horizon Discovery where they held the role of Manager, Immuno-Oncology from September 2017 to May 2020. Prior to that, they were a Team Leader, Immuno-Oncology from December 2015 to August 2017. Cristina'sresponsibilities at Horizon Discovery included using cutting-edge technologies for genome editing, leading CRISPR-Cas9 screenings, and performing genetic and pharmacologic screens of arrayed libraries.

Before joining Horizon Discovery, Cristina worked at REDX ONCOLOGY LTD as a Team Leader, Immunologist from September 2014 to December 2015. At REDX ONCOLOGY, they contributed to multiple high-priority programmes focused on developing small molecule therapeutics for cancer treatment. Cristina applied various immunology techniques to study the behavior of primary immune cells in response to small molecule treatments.

Cristina's earlier experience includes working as a Postdoctoral Research Scientist at Barts Cancer Institute, Queen Mary University of London from August 2011 to September 2014. During this time, they designed and managed research projects related to regulatory B cells in human pancreatic cancer.

Cristina also worked as a Postdoctoral Researcher at Institut Curie from November 2010 to July 2011, where they extended their PhD research and started new projects on IL-18 and TSLP in human breast cancer. Cristina's research expertise includes flow cytometry, ELISA, IHC, primary tumor digestion, immune cell isolation, characterization, and culture.

Overall, Cristina Ghirelli has a diverse background in immunology and cancer research, holding leadership roles and contributing to various research projects.

Cristina Ghirelli has a diverse education history in the field of immunology and cancer biology. Cristina started their academic journey in 1998 at the Università degli Studi di Modena e Reggio Emilia, where they pursued their undergraduate studies. The specific degree name and field of study during this period are not provided.

In 2004, Cristina Ghirelli embarked on their Master of Science degree at the Bioindustry Park del Canavese, which is part of the Università degli Studi di Torino. Cristina'sfocus during this time was on cancer biology.

Continuing their educational pursuit, Cristina Ghirelli enrolled at Paris-Sud University (Paris XI) in 2005. Here, they participated in the European Leonardo da Vinci programme, which centered around immunology. This experience likely provided their with a unique opportunity to expand their knowledge in this specific area of study.

Building on their previous experiences, Cristina Ghirelli then pursued a Doctor of Philosophy (Ph.D.) degree in Immunology at Paris-Sud University (Paris XI) from 2006 to 2010. This advanced academic journey allowed their to delve deeper into the field of immunology and contribute to the existing body of knowledge.

Based on the provided information, it can be summarized that Cristina Ghirelli possesses a solid educational foundation in immunology and cancer biology, culminating in a Ph.D. degree.